Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2024 Earnings Call Transcript August 7, 2024

Madrigal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-7.10057, expectations were $-7.55.

Operator: Good day, and thank you for standing by. Welcome to the Madrigal Pharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers presentation there will be a question and answer session. As a reminder,...